Preclinical evaluation of heat shock protein 90 inhibitor, IPI-504 in human pancreatic xenografts.

被引：0
|
作者：
Song, Dongweon
Jimeno, Antonio
Kulesza, Piotr
Messersmith, Wells
Zhang, Xian Feng
Bouraoud, Nadia
Pien, Christine
Tong, Jeffery
Hidalgo, Manuel
机构：
[1] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
[2] Infin Pharmaceut Inc, Cambridge, MA USA
来源：
CANCER RESEARCH | 2006年 / 66卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5475
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Inhibition and flare patterns of metabolic response to the heat shock protein 90 (Hsp90) inhibitor IPI-504 visualized by FDG-PET in patients (pts) with advanced gastrointestinal stromal tumors (GIST) resistant to tyrosine kinase inhibitor (TKI) therapy
    Van den Abbeele, A. D.
    Yap, J. T.
    Grayzel, D. S.
    Walker, J.
    Demetri, G. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [22] Inhibition of the Heat Shock Protein 90 (Hsp90) chaperone with the novel agent IPI-504 to overcome resistance to tyrosine kinase inhibitors (TKIs) in metastatic GIST: Updated results of a phase I trial
    Demetri, G. D.
    George, S.
    Morgan, J. A.
    Wagner, A.
    Quigley, M. T.
    Polson, K.
    Pokela, J.
    van den Abbeele, A.
    Adams, J.
    Grayzel, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [23] Phosphorylated Heatshockprotein-90 is overexpressed in core binding factor leukemias (CBFL) and can effectively be targeted by the HSP90 inhibitor IPI-504
    Schittenhelm, M. M.
    Grandl, T.
    Normant, E.
    Salih, H. R.
    Kampa-Schittenhelm, K. M.
    ONKOLOGIE, 2012, 35 : 116 - 116
  • [24] Overcoming resistance to tyrosine kinase inhibitors (TKIs) through inhibition of Heat Shock Protein 90 (Hsp90) chaperone function in patients with metastatic GIST: results of a Phase I Trial of IPI-504, a water-soluble Hsp90 inhibitor
    Demetri, G. D.
    George, S.
    Morgan, J. A.
    van den Abbeele, A.
    Quigley, M. T.
    Fletcher, J. A.
    Normandt, E.
    Patterson, J.
    Adams, J.
    Grayzel, D.
    EJC SUPPLEMENTS, 2006, 4 (12): : 173 - 173
  • [25] Profiling Hsp90 differential expression and the molecular effects of the Hsp90 inhibitor IPI-504 in high-grade glioma models
    Di, Kaijun
    Keir, Stephen T.
    Alexandru-Abrams, Daniela
    Gong, Xing
    Nguyen, Howard
    Friedman, Henry S.
    Bota, Daniela A.
    JOURNAL OF NEURO-ONCOLOGY, 2014, 120 (03) : 473 - 481
  • [26] Profiling Hsp90 differential expression and the molecular effects of the Hsp90 inhibitor IPI-504 in high-grade glioma models
    Kaijun Di
    Stephen T. Keir
    Daniela Alexandru-Abrams
    Xing Gong
    Howard Nguyen
    Henry S. Friedman
    Daniela A. Bota
    Journal of Neuro-Oncology, 2014, 120 : 473 - 481
  • [27] Hsp90 inhibitor IPI-504 demonstrates antitumor activity against a panel of neuroendocrine/carcinoid cell lines in vitro and in vivo
    Lim, Alice R.
    Slocum, Kelly
    Denyeko, Igor
    West, Kip A.
    Palombella, Vito J.
    Fritz, Christian C.
    Vosburgh, Evan
    Normant, Emmanuel Y.
    MOLECULAR CANCER THERAPEUTICS, 2009, 8 (12)
  • [28] Antitumor Activity of the Hsp90 Inhibitor IPI-504 in HER2-Positive Trastuzumab-Resistant Breast Cancer
    Scaltriti, Maurizio
    Serra, Violeta
    Normant, Emmanuel
    Guzman, Marta
    Rodriguez, Olga
    Lim, Alice R.
    Slocum, Kelly L.
    West, Kip A.
    Rodriguez, Varenka
    Prudkin, Ludmila
    Jimenez, Jose
    Aura, Claudia
    Baselga, Jose
    MOLECULAR CANCER THERAPEUTICS, 2011, 10 (05) : 817 - 824
  • [29] Inhibition of heat shock protein 90 (Hsp90) with the novel agent IPI-504 in metastatic GIST following failure of tyrosine kinase inhibitors (TKIs) or other sarcomas: Clinical results from phase I trial
    Wagner, A. J.
    Morgan, J. A.
    Chugh, R.
    Rosen, L. S.
    George, S.
    Gordon, M. S.
    Devine, C. M.
    Van den Abbeele, A. D.
    Grayzel, D.
    Demetri, G. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [30] Heat Shock Protein 90 Inhibitor Effects on Pancreatic Cancer Cell Cultures
    Gulla, Aiste
    Kazlauskas, Egidijus
    Liang, Hong
    Strupas, Kestutis
    Petrauskas, Vytautas
    Matulis, Daumantas
    Eshleman, James R.
    PANCREAS, 2021, 50 (04) : 625 - 632
12345